Ki-67 expression gives additional prognostic information on St. Gallen 2007 and adjuvant! online risk categories in early breast cancer

Annals of Surgical Oncology

Volumn 16, Issue 5, 2009, Pages 1112-1121

  Jung, So Youn ^a   Han, Wonshik ^b   Lee, Jong Won ^b   Ko, Eunyoung ^b   Kim, Eunkyu ^b   Yu, Jong Han ^b   Moon, Hyeong Gon ^b   Park, In Ae ^b   Oh, Do Youn ^b   Im, Seock Ah ^b   Kim, Tae You ^b   Hwang, Ki Tae ^b   Kim, Sung Won ^b   Noh, Dong Young ^b  

^a National Cancer Center   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; ESTROGEN RECEPTOR; FLUOROURACIL; KI 67 ANTIGEN; METHOTREXATE; PROGESTERONE RECEPTOR; PROTEIN BCL 2;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; DISEASE FREE SURVIVAL; EARLY CANCER; FEMALE; HIGH RISK POPULATION; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PROGNOSIS; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERNET; KI-67 ANTIGEN; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RISK ASSESSMENT; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 64249146434     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0334-7     Document Type: Article

References (41)

1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687-717.
2. A Goldhirsch WC Wood RD Gelber 2003 Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer J Clin Oncol 21 3357 3365
3. J Boyages B Chua R Taylor 2002 Use of the St Gallen classification for patients with node-negative breast cancer may lead to overuse of adjuvant chemotherapy Br J Surg 89 789 796
4. E Iwamoto T Fukutomi S Akashi-Tanaka 2001 Validation and problems of St Gallen recommendations of adjuvant therapy for node-negative invasive breast cancer in Japanese patients Jpn J Clin Oncol 31 259 262
5. PM Ravdin LA Siminoff GJ Davis 2001 Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer J Clin Oncol 19 980 991
6. M Buyse S Loi L van't Veer 2006 Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer J Natl Cancer Inst 98 1183 1192
7. MH Galea RW Blamey CE Elston IO Ellis 1992 The Nottingham Prognostic Index in primary breast cancer Breast Cancer Res Treat 22 207 219
8. SH Ahn BH Son SW Kim 2007 Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea-a report from the Korean Breast Cancer Society J Clin Oncol 25 2360 2368
9. JM Sun W Han SA Im 2004 A combination of HER-2 status and the St. Gallen classification provides useful information on prognosis in lymph node-negative breast carcinoma Cancer 101 2516 2522
10. L Harris H Fritsche R Mennel 2007 American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer J Clin Oncol 25 5287 5312
11. M Colozza E Azambuja F Cardoso 2005 Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? Ann Oncol 16 1723 1739
12. J Gerdes L Li C Schlueter 1991 Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67 Am J Pathol 138 867 873
13. ML Cher K Chew W Rosenau PR Carroll 1995 Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression Prostate 26 87 93
14. M Dowsett IE Smith SR Ebbs 2007 Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer J Natl Cancer Inst 99 167 170
15. M Caly P Genin AA Ghuzlan 2004 Analysis of correlation between mitotic index, MIB1 score and S-phase fraction as proliferation markers in invasive breast carcinoma Methodological aspects and prognostic value in a series of 257 cases Anticancer Res 24 3283 3288
16. S Paik S Shak G Tang 2004 A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 2817 2826
17. E de Azambuja F Cardoso G De Castro Jr 2007 Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12, 155 patients Br J Cancer 96 1504 1513
18. H Trihia S Murray K Price 2003 Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors-a surrogate marker? Cancer 97 1321 1331
19. A Molino R Micciolo M Turazza 1997 Ki-67 immunostaining in 322 primary breast cancers: associations with clinical and pathological variables and prognosis Int J Cancer 74 433 437
20. A Goldhirsch WC Wood RD Gelber 2007 Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007 Ann Oncol 18 1133 1144
21. CW Elston IO Ellis 1991 Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 19 403 410
22. AM Billgren E Tani A Liedberg 2002 Prognostic significance of tumor cell proliferation analyzed in fine needle aspirates from primary breast cancer Breast Cancer Res Treat 71 161 170
23. RW Brown CD Allred GM Clark 1996 Prognostic value of Ki-67 compared to S-phase fraction in axillary node-negative breast cancer Clin Cancer Res 2 585 592
24. O Erdem A Dursun U Coskun N Gunel 2005 The prognostic value of p53 and c-erbB-2 expression, proliferative activity and angiogenesis in node-negative breast carcinoma Tumori 91 46 52
25. P Rudolph P Alm HJ Heidebrecht 1999 Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer J Natl Cancer Inst 91 271 278
26. T Pietilainen P Lipponen S Aaltomaa 1996 The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer J Cancer Res Clin Oncol 122 687 692
27. J Jacquemier C Ginestier J Rougemont 2005 Protein expression profiling identifies subclasses of breast cancer and predicts prognosis Cancer Res 65 767 779
28. Y Wang JG Klijn Y Zhang 2005 Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Lancet 365 671 679
29. MJ van de Vijver YD He LJ van't Veer 2002 A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 347 1999 2009
30. EP Malaise N Chavaudra M Tubiana 1973 The relationship between growth rate, labelling index and histological type of human solid tumours Eur J Cancer 9 305 312
31. PN Dean F Dolbeare H Gratzner 1984 Cell-cycle analysis using a monoclonal antibody to BrdUrd Cell Tissue Kinet 17 427 436
32. P Quirke JE Dyson 1986 Flow cytometry: methodology and applications in pathology J Pathol 149 79 87
33. AD Thor S Liu DH Moore II SM Edgerton 1999 Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer J Clin Oncol 17 470 477
34. R Lau R Grimson C Sansome 2001 Low levels of cell cycle inhibitor p27kip1 combined with high levels of Ki-67 predict shortened disease-free survival in T1 and T2 invasive breast carcinomas Int J Oncol 18 17 23
35. M Railo J Lundin C Haglund 2007 Ki-67, p53, ER receptors, ploidy and S phase as long-term prognostic factors in T1 node-negative breast cancer Tumour Biol 28 45 51
36. F Spyratos M Ferrero-Pous M Trassard 2002 Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value Cancer 94 2151 2159
37. A Volpi O Nanni F De Paola 2003 HER-2 expression and cell proliferation: prognostic markers in patients with node-negative breast cancer J Clin Oncol 21 2708 2712
38. SM Veronese M Gambacorta O Gottardi 1993 Proliferation index as a prognostic marker in breast cancer Cancer 71 3926 3931
39. M Palazzi D De Tomasi C D'Affronto 2002 Are international guidelines for the prescription of adjuvant treatment for early breast cancer followed in clinical practice? Results of a population-based study on 1547 patients Tumori 88 503 506
40. F Roila E Ballatori L Patoia 2003 Adjuvant systemic therapies in women with breast cancer: an audit of clinical practice in Italy Ann Oncol 14 843 848
41. IA Olivotto CD Bajdik PM Ravdin 2005 Population-based validation of the prognostic model Adjuvant! for early breast cancer J Clin Oncol 23 2716 2725